search
Company Information
USD
13.23
0.5 (3.9%)
NASDAQ:HROW, HARROW INC
Industry: Drug Manufacturers - Specialty & Generic
End of Day: 28 March 2024 GMT-4
Harrow Inc is a leading eyecare pharmaceutical company engaged in the discovery, development, and commercialization of innovative ophthalmic pharmaceutical products for the U.S. market. Harrow helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans each year.

Address

102 Woodmont Boulevard
Suite 610

Classification

Sector

Healthcare

Industry Group

Drug Manufacturers

Industry

Drug Manufacturers - Specialty & Generic

Key Executives

Ms. Lauren P. Silvernail
Director
Dr. Adrienne L. Graves,PhD
Director
Mr. John Saharek
CEO, Divisional/Other Executive Officer/President, Divisional
Mr. Mark L. Baum
CEO/Chairman of the Board/Director/Founder
Mr. Andrew R. Boll
CFO/Chief Accounting Officer/Secretary
Ms. Teresa F. Sparks
Director
Mr. Perry J. Sternberg
Director
Dr. Martin A. Makary, M.D.
Director

Ownership

Institution Holdings

Opaleye Management Inc
3,820,000 (10.878%)
Private Capital Management, LLC
2,794,497 (7.958%)
BlackRock Inc
2,220,538 (6.323%)
BRAIDWELL LP
1,808,684 (5.150%)
Vanguard Group Inc
1,808,552 (5.150%)
Morgan Stanley - Brokerage Accounts
1,366,741 (3.892%)
BlackRock Fund Advisors
1,107,349 (3.153%)
Vanguard Investments Australia Ltd
997,682 (2.841%)
Deutsche Bank AG
748,855 (2.132%)
DWS Investments UK Limited
735,579 (2.095%)

Individual Holdings

Mr. Mark L. Baum
2,128,525 (6.061%)
Mr. Andrew R. Boll
568,089 (1.618%)
Mr. John Saharek
254,803 (0.726%)
Dr. Martin A. Makary, M.D.
45,000 (0.128%)

Funds Holdings

iShares Russell 2000 ETF
724,637 (2.063%)
Vanguard Institutional Extnd Mkt Idx Tr
459,074 (1.307%)
Fidelity Small Cap Index Fund
301,130 (0.857%)
iShares Russell 2000 Growth ETF
266,334 (0.758%)
Bridgeway Ultra Small Company Fund
190,500 (0.542%)
Fidelity Extended Market Index Fund
178,373 (0.508%)
Private Capital Management Value Fund
153,500 (0.437%)
Royce Micro Cap Series Fund
125,200 (0.357%)
SAM Venture Growth
114,609 (0.326%)
Kennedy Micro Cap
107,649 (0.307%)

Details

Overview Company Info Key Ratios Income Balance Sheet Cash Flow
Make Smart Investment Choices